news
09 September, 2022 09 September, 2022 Opinion of the Transparency Council – Health policy programme for the prevention of meningococcal infections for children in the Municipality of Kielce
read more09 September, 2022 Opinion of the Transparency Council – health policy programme on infertility treatment (district olkuski)
read more09 September, 2022 Opinion of the Transparency Council – health policy programme on in vitro fertilisation (Jelenia Góra)
read more09 September, 2022 Position of the Transparency Council – Tript-OH (oksytryptan)
read more08 September, 2022 The Meeting of the Transparency Council No. 36/2022 of 12.09.2022
read more05 August, 2022 The Meeting of the Transparency Council No. 32/2022 of 16.08.2022
read more04 August, 2022 The Meeting of the Transparency Council No. 31/2022 of 11.08.2022
read more02 August, 2022 The Meeting of the Tariffs Council No. 19/2022 of 11.08.2022
read more28 July, 2022 The Meeting of the Transparency Council No. 30/2022 of 01.08.2022.
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on therapeutic rehabilitation (town of Żyrardów)
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on breast cancer prevention (town of Sieradz)
read more26 July, 2022 Opinion of the Transparency Council – changes to the drug programme B.61
read more26 July, 2022 Opinion of the Transparency Council – active substance ipratropii bromidum
read more26 July, 2022 Opinion of the Transparency Council – active substances fenoteroli hydrobromidum + ipratropii bromidum
read more26 July, 2022 Opinion of the Transparency Council – active substance prednisone
read more26 July, 2022 Opinion of the Transparency Council – active substances amiloridum + hydrochlorothiazidum
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on medical rehabilitation (Municipality of Mielno)
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on detection of vision defects (Municipality of Chociwel)
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on detection of vision defects (town of Będzin)
read more26 July, 2022 Position of the Transparency Council – Rezurock (belumosudil)
read more26 July, 2022 Position of the Transparency Council – Yervoy (ipilimumab)
read more26 July, 2022 Position of the Transparency Council – Opdivo (nivolumab)
read more26 July, 2022 Opinion of the Transparency Council – combining drug programmes B.29 and B.46
read more